Pulmonary Fibrosis Under Chemotherapy with Oxaliplatin, 5-fluorouracil, and Leucovorin

被引：0

作者：

Jung, Jin Yong ^{[1
]}

Hur, Gyu Young ^{[1
]}

Jung, Ki Hwan ^{[1
]}

Jung, Hae Chul ^{[1
]}

Lee, Sung Yong ^{[1
]}

Choi, In Keun ^{[1
]}

Lee, Sang Yeub ^{[1
]}

Kim, Je Hyeong ^{[1
]}

Seo, Jae Hong ^{[1
]}

Shin, Chol ^{[1
]}

Shim, Jae Jeong ^{[1
]}

In, Kwang Ho ^{[1
]}

Kang, Kyung Ho ^{[1
]}

Yoo, Se Hwa ^{[1
]}

机构：

[1] Korea Univ, Coll Med, Dept Internal Med, Seoul, South Korea

来源：

TUBERCULOSIS AND RESPIRATORY DISEASES | 2005年 / 59卷 / 05期

关键词：

Oxaliplatin; Fluorouracil; Leucovorin; Chemotherapy; Pulmonary fibrosis;

D O I：

10.4046/trd.2005.59.5.536

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The combination of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) has recently been shown to be beneficial in advanced colorectal and gastric cancers. The side effects of this regimen include neutropenia, diarrhea and neurosensory toxicity. However, case reports on the pulmonary toxicities of this regimen are very limited. Especially, the development of pulmonary fibrosis has never been cited in the literature. Herein is reported the case of a patient treated with oxaliplatin, 5-fluorouracil and leucovorin combination chemotherapy in whom pulmonary fibrosis developed, but which improved after steroid pulse therapy.

引用

页码：536 / 540

页数：5

共 50 条

[31] Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer
Yao Yang
Sun Yuan-jue
Zhao Hui
Guo Yue-Wu
Lin Feng
Cai Xun
Tang Xiao-chun
Tang Li-na
Zhang Wei
CHINESE MEDICAL JOURNAL, 2006, 119 (21) : 1829 - 1833
[32] Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer
YAO Yang
中华医学杂志(英文版), 2006, (21) : 1829 - 1833
[33] Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC)
Cavanna, Luigi
Artioli, Fabrizio
Codignola, Claudio
Lazzaro, Antonio
Rizzi, Anna
Gamboni, Alessandro
Rota, Luigina
Rodino, Carmelina
Boni, Fabrizio
Iop, Aldo
Zaniboni, Alberto
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (04): : 371 - 375
[34] Oxaliplatin,Fluorouracil and Leucovorin (FOLFOX) as First-line Chemotherapy for Metastatic or Recurrent Colorectal Cancer Patients
Bing Han Ruihua Xu Yanxia Shi Huiyan Luo Xiaojuan Xiang Yuhong Li Li Zhang Tongyu Lin Youjian HeDepartment of Medical Oncology
Chinese Journal of Clinical Oncology, 2007, (06) : 397 - 400
[35] Oxidative damage to guanine nucleosides following combination chemotherapy with 5-fluorouracil and oxaliplatin
Shoaib Afzal
Søren Astrup Jensen
Jens Benn Sørensen
Trine Henriksen
Allan Weimann
Henrik Enghusen Poulsen
Cancer Chemotherapy and Pharmacology, 2012, 69 : 301 - 307
[36] Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study
B Neri
P Pantaleo
E Giommoni
R Grifoni
C Paoletti
V Rotella
D Pantalone
A Taddei
A Mercatelli
P Tonelli
British Journal of Cancer, 2007, 96 : 1043 - 1046
[37] Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity
Joanna E. Fardell
Janette Vardy
Jeanette D. Shah
Ian N. Johnston
Psychopharmacology, 2012, 220 : 183 - 193
[38] Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study
Neri, B.
Pantaleo, P.
Giommoni, E.
Grifoni, R.
Paoletti, C.
Rotella, V.
Pantalone, D.
Taddei, A.
Mercatelli, A.
Tonelli, P.
BRITISH JOURNAL OF CANCER, 2007, 96 (07) : 1043 - 1046
[39] Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer A Population-Based Analysis
Sanoff, Hanna K.
Carpenter, William R.
Freburger, Janet
Li, Ling
Chen, Kun
Zullig, Leah L.
Goldberg, Richard M.
Schymura, Maria J.
Schrag, Deborah
CANCER, 2012, 118 (17) : 4309 - 4320
[40] Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial
Garufi, C.
Torsello, A.
Tumolo, S.
Ettorre, G. M.
Zeuli, M.
Campanella, C.
Vennarecci, G.
Mottolese, M.
Sperduti, I.
Cognetti, F.
BRITISH JOURNAL OF CANCER, 2010, 103 (10) : 1542 - 1547

← 1 2 3 4 5 →